VIPR2 anticorps (Extracellular Domain, N-Term)
Aperçu rapide pour VIPR2 anticorps (Extracellular Domain, N-Term) (ABIN2384691)
Antigène
Voir toutes VIPR2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Extracellular Domain, N-Term
-
Réactivité croisée
- Rat (Rattus)
-
Réactivité croisée (Details)
- Calculated cross reactivity: Rt
-
Attributs du produit
- Vasoactive intestinal Polypeptide Receptor 2 (VIP Receptor 2, VIP2R, VIPR2, Helodermin Preferring VIP Receptor, Helodermin-preferring VIP Receptor, Pituitary Adenylate Cyclase Activating Polypeptide Type III Receptor, PACAP Type III Receptor, VPAC2, VPAC2 Receptor)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- 19aa peptide from rat VIPR2. Location: ~N-terminus, Extracellular domain. No significant homology is observed with VIPR1. Species Sequence Homology: Mouse - 94%, Human - 86%.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- Supplied as a lyophilized powder from PBS, 0.05 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
-
Autre désignation
- Vasoactive Intestinal Polypeptide Receptor 2
-
Pathways
- cAMP Metabolic Process
Antigène
-